Nestlé revealed it will close two of its Health Science plants in the United States. The Swiss company explained that this move is a strategy to increase efficiency in its health nutrition business unit.
Nestlé Health Science is the company’s division that is focused on the research, development, and manufacturing of healthy and medical nutrition products. It is mainly known for its Nutren and Meritene brands. At any rate, it is said to be currently in the process of bringing together its supply chain network to boost efficiency.
The company issued a Worker Adjustment and Retraining Notification (WARN), and Nestlé Health Science’s director of project management and HR special projects, Chris Richardson, said in the memo that due to the closure of their two facilities, more than 300 employees are set to lose their jobs.
To be more exact, Richardson stated in the WARN that “312 positions will be eliminated on a permanent basis.” The two plants that would be shut down are those located in Findlay and Robinson Township, and the job cuts are expected to begin in late June.
“There are no bumping rights at the impacted facility. The employees have no elected collective bargaining representative,” the project management director added.
According to Penn Live News, Nestlé Health Sciences filed the WARN notice at the Pennsylvania Department of Industry. It was indicated in the memo that the company’s facilities at 600 Boyce Road, under the name of HVL LLC, and 112 Technology Drive in Pittsburgh, listed under the name Pure Encapsulations are set to cease operations.
The WARN Act is a government regulation that protects employees, communities, and even the families of workers in the U.S. This law provides protection by requiring companies and other employers to notify everyone if they are planning to close business. It is a must for this type of notice to be posted 60 days in advance.


Gold and Silver Prices Rebound After Volatile Week Triggered by Fed Nomination
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Washington Post Publisher Will Lewis Steps Down After Layoffs
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock
Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
South Africa Eyes ECB Repo Lines as Inflation Eases and Rate Cuts Loom
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals
Trump’s Inflation Claims Clash With Voters’ Cost-of-Living Reality 



